Company Information

Boehringer Ingelheim Pharmaceuticals, Inc.

Member Type

Associate

Organization Type

Manufacturer

Description

Value Through Innovation is Our Vision Improving the health and lives of humans and animals is the goal of the research-driven biopharmaceutical company Boehringer Ingelheim. The focus is on diseases in areas with a high unmet medical need. The company therefore concentrates on developing innovative therapies that can improve and extend lives. In Animal Health, Boehringer Ingelheim is one of the world’s leading providers of vaccines, therapeutics and preventative care offering that protect animals from disease and pain. Family-owned since its foundation in 1885, Boehringer Ingelheim is one of the top 20 companies in the pharmaceutical industry. Our aim is to transform the lives of patients –across generations. This goal inspires all of our over 53,000 employees who create value through innovation. In 2022, Boehringer Ingelheim achieved net sales of 24.1 billion euros.

Contact Information

900 Ridgebury Road

Ridgefield, CT 06877-0368

http://www.boehringer-ingelheim.com

(800)344-4095

Services Offered

Branded

HIV/AIDS (HIV)

Staff

  • McQuade, Mary

    AD, Trade Operations, Boehringer Ingelheim Pharmaceuticals, Inc.
  • Menzie, Janet

    Boehringer Ingelheim Pharmaceuticals, Inc.
  • Monteiro, Manuela

    Trade Coordinator, Boehringer Ingelheim Pharmaceuticals, Inc.
  • Mueller, Carrie

    National Account Director, Boehringer Ingelheim Pharmaceuticals, Inc.
  • Napoli, Thomas

    AD, Security Governance Americas, Boehringer Ingelheim Pharmaceuticals, Inc.
  • Nell, Connor

    National Account Director, Boehringer Ingelheim Pharmaceuticals, Inc.
  • Projansky, Steven

    Director, Trade Operations, Boehringer Ingelheim Pharmaceuticals, Inc.
  • Ratai, Lindsay

    Boehringer Ingelheim Pharmaceuticals, Inc.
  • Reiss, Donna

    Trade & Specialty Analyst, Boehringer Ingelheim Pharmaceuticals, Inc.
  • Ripka, Sheryl

    Security Manager, Gainesville, GA, Boehringer Ingelheim Pharmaceuticals, Inc.